Listing 1 - 10 of 11 | << page >> |
Sort by
|
Choose an application
Advertising --- Drugs --- Pharmaceutical industry --- Pharmaceutical policy --- Prescription pricing --- Prices --- Research --- Finance. --- Costs. --- Costs --- Finance --- #SBIB:316.334.3M50 --- 661.12 --- 343.53 --- Organisatie van de gezondheidszorg: algemeen, beleid --- Pharmaceutical products --- Commerciele fraude. Industriele fraude. Ongeoorloofde concurrentie --- 343.53 Commerciele fraude. Industriele fraude. Ongeoorloofde concurrentie --- 661.12 Pharmaceutical products --- Drug industry --- Drug trade --- Medicine industry --- Medicines industry --- Prescription medicine industry --- Chemical industry --- Medicaments --- Medications --- Medicine (Drugs) --- Medicines (Drugs) --- Pharmaceuticals --- Prescription drugs --- Bioactive compounds --- Medical supplies --- Pharmacopoeias --- Chemotherapy --- Materia medica --- Pharmacology --- Pharmacy --- Ads --- Advertisements --- Advertising, Consumer --- Advertising, Retail --- Advertising, Store --- Commercial speech --- Consumer advertising --- Retail advertising --- Speech, Commercial --- Store advertising --- Business --- Communication in marketing --- Industrial publicity --- Retail trade --- Advertisers --- Branding (Marketing) --- Propaganda --- Public relations --- Publicity --- Sales promotion --- Selling --- Research&delete& --- Pharmaceutical industry - United States - Costs --- Drugs - Prices - United States --- Drugs - Research - United States - Finance --- Prescription pricing - United States --- Advertising - Drugs - United States --- Pharmaceutical policy - United States
Choose an application
Pharmaceutical industry --- Drugs --- Prescription pricing --- Advertising --- Pharmaceutical policy --- Costs --- Prices --- Research --- Finance --- 661.12 --- 343.53 --- Pharmaceutical products --- Commerciele fraude. Industriele fraude. Ongeoorloofde concurrentie --- Finance. --- Costs. --- 343.53 Commerciele fraude. Industriele fraude. Ongeoorloofde concurrentie --- 661.12 Pharmaceutical products --- Drug industry --- Drug trade --- Medicine industry --- Medicines industry --- Prescription medicine industry --- Chemical industry --- Medicaments --- Medications --- Medicine (Drugs) --- Medicines (Drugs) --- Pharmaceuticals --- Prescription drugs --- Bioactive compounds --- Medical supplies --- Pharmacopoeias --- Chemotherapy --- Materia medica --- Pharmacology --- Pharmacy --- Ads --- Advertisements --- Advertising, Consumer --- Advertising, Retail --- Advertising, Store --- Commercial speech --- Consumer advertising --- Retail advertising --- Speech, Commercial --- Store advertising --- Business --- Communication in marketing --- Industrial publicity --- Retail trade --- Advertisers --- Branding (Marketing) --- Propaganda --- Public relations --- Publicity --- Sales promotion --- Selling --- Research&delete& --- 615.2 --- 615.1.01 --- geneesmiddelen (zie ook 615.035, 615.35) --- farmaceutische industrie --- Pharmaceutical industry - United States - Costs --- Drugs - Prices - United States --- Drugs - Research - United States - Finance --- Prescription pricing - United States --- Advertising - Drugs - United States --- Pharmaceutical policy - United States
Choose an application
Breast implants --- Breast implants --- Products liability --- Complications. --- Law and legislation --- Breast implants
Choose an application
Choose an application
Pathological anatomy and histology --- Pathology --- PATHOLOGY --- Pathology.
Choose an application
Pathology --- Pathologie
Choose an application
Choose an application
Choose an application
Choose an application
An anthology Malcolm Gladwell has called "riveting and indispensable," The Best Business Writing is a far-ranging survey of business's dynamic relationship with politics, culture, and life. This year's selections include John Markoff (New York Times) on innovations in robot technology and the decline of the factory worker; Evgeny Morozov (New Republic) on the questionable value of the popular TED conference series and the idea industry behind it; Paul Kiel (ProPublica) on the ripple effects of the ongoing foreclosure crisis; and the infamous op-ed by Greg Smith, published in the New York Times, announcing his break with Goldman Sachs over its trading practices and corrupt corporate ethos.Jessica Pressler (New York) delves into the personal and professional rivalry between former spouses and fashion competitors Tory and Christopher Burch. Peter Whoriskey (Washington Post) exposes the human cost of promoting pharmaceuticals for off-label uses. Charles Duhigg and David Barboza (New York Times) investigate Apple's unethical labor practices in China. Max Abelson (Bloomberg) reports on Wall Street's amusing reaction to the diminishing annual bonus. Mina Kimes (Fortune) recounts the grisly story of a company's illegal testing-and misuse-of a medical device for profit, and Jeff Tietz (Rolling Stone) composes one of the most poignant and comprehensive portraits of the financial crisis's dissolution of the American middle class.
Journalism & Communications --- Journalism --- Business --- Businesspeople --- Business enterprises --- Business organizations --- Businesses --- Companies --- Enterprises --- Firms --- Organizations, Business --- Business people --- Business persons --- Businesspersons --- Entrepreneurs --- Professional employees --- Trade --- Economics --- Management --- Commerce --- Industrial management --- Corrupt practices
Listing 1 - 10 of 11 | << page >> |
Sort by
|